These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11568824)

  • 1. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.
    Slavik RS; Tisdale JE; Borzak S
    Prog Cardiovasc Dis; 2001; 44(2):121-52. PubMed ID: 11568824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
    Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Milan DJ; Saul JP; Somberg JC; Molnar J
    Cardiology; 2017; 136(1):52-60. PubMed ID: 27554842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.
    Miller MR; McNamara RL; Segal JB; Kim N; Robinson KA; Goodman SN; Powe NR; Bass EB
    J Fam Pract; 2000 Nov; 49(11):1033-46. PubMed ID: 11093570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
    Boriani G; Biffi M; Capucci A; Botto G; Broffoni T; Ongari M; Trisolino G; Rubino I; Sanguinetti M; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2470-4. PubMed ID: 9825369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation.
    Markey GC; Salter N; Ryan J
    J Emerg Med; 2018 Mar; 54(3):320-327. PubMed ID: 29269083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    Humphries KH; Kerr CR; Steinbuch M; Dorian P;
    CMAJ; 2004 Sep; 171(7):741-5. PubMed ID: 15451836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
    Naccarelli GV; Dell'Orfano JT; Wolbrette DL; Patel HM; Luck JC
    Am J Cardiol; 2000 May; 85(10A):36D-45D. PubMed ID: 10822039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is oral sotalol effective in converting atrial fibrillation to sinus rhythm?
    Ferreira E; Sunderji R; Gin K
    Pharmacotherapy; 1997; 17(6):1233-7. PubMed ID: 9399605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I; Petrela E; Kondili A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.